From phage display to nanoparticle delivery: Functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker

Bioconjugate Chemistry

Volumn 24, Issue 1, 2013, Pages 85-96

  Gray, Bethany Powell ^a   Li, Shunzi ^a   Brown, Kathlynn C ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHELATION; CONTROLLED DRUG DELIVERY; CYTOLOGY; LIGANDS; LIPOSOMES; NANOPARTICLES; SCAFFOLDS; SCAFFOLDS (BIOLOGY); TARGETED DRUG DELIVERY; TOXICITY;

CANCER BIOMARKERS; CELL TYPES; HIGH AFFINITY; MONOMERICS; NANOPARTICLE SURFACE; PHAGE-DISPLAY; TARGET CELLS; TARGETED DELIVERY; TETRAMERIC; VALENCIES;

PEPTIDES;

ALPHAVBETA6 INTEGRIN; DOXORUBICIN; H2009.1 PEPTIDE; NANOPARTICLE; PEPTIDE DERIVATIVE; TETRAMER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; LUNG NON SMALL CELL CANCER; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PROTEIN EXPRESSION; PROTEIN SUBUNIT; PROTEIN TARGETING; SURFACE PROPERTY;

EID: 84872592017     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300498d     Document Type: Article

References (47)

1. Alley, S. C., Okeley, N. M., and Senter, P. D. (2010) Antibody-drug conjugates: targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14, 529-537
2. Reichert, J. M. and Valge-Archer, V. E. (2007) Development trends for monoclonal antibody cancer therapeutics Nat. Rev. Drug Discovery 6, 349-356
3. Bray, B. L. (2003) Innovation: Large-scale manufacture of peptide therapeutics by chemical synthesis Nat. Rev. Drug Discovery 2, 587-593
4. Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228, 1315-1317
5. Smith, G. P. and Petrenko, V. A. (1997) Phage Display Chem. Rev. 97, 391-410
6. Kehoe, J. W. and Kay, B. K. (2005) Filamentous phage display in the new millennium Chem. Rev. 105, 4056-4072
7. Brown, K. C. (2010) Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications Curr. Pharm. Des. 16, 1040-1054
8. Aina, O. H., Liu, R., Sutcliffe, J. L., Marik, J., Pan, C. X., and Lam, K. S. (2007) From combinatorial chemistry to cancer-targeting peptides Mol. Pharmaceutics 4, 631-651
9. Barry, M. A., Dower, W. J., and Johnston, S. A. (1996) Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries Nat. Med. 2, 299-305
10. Pasqualini, R. and Ruoslahti, E. (1996) Organ targeting in vivo using phage display peptide libraries Nature 380, 364-366
11. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2754-2794
12. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2000) Synthetic multivalent ligands in the exploration of cell-surface interactions Curr. Opin. Chem. Biol. 4, 696-703
13. Oyama, T., Sykes, K. F., Samli, K. N., Minna, J. D., Johnston, S. A., and Brown, K. C. (2003) Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents Cancer Lett. 202, 219-230
14. Helms, B. A., Reulen, S. W. A., Nijhuis, S., Graaf-Heuvelmans, P. T. H. M. d., Merkx, M., and Meijer, E. W. (2009) High-affinity peptide-based collagen targeting using synthetic phage mimics: from phage display to dendrimer display J. Am. Chem. Soc. 131, 11683-11685
15. Bastings, M. M. C., Helms, B. A., van Baal, I., Hackeng, T. M., Merkx, M., and Meijer, E. W. (2011) From phage display to dendrimer display: insights into multivalent binding J. Am. Chem. Soc. 133, 6636-6641
16. De, J., Chang, Y.-C., Samli, K. N., Schisler, J. C., Newgard, C. B., Johnston, S. A., and Brown, K. C. (2005) Isolation of a mycoplasma-specific binding peptide from an unbiased phage-displayed peptide library Mol. Biosyst. 1, 149-157
17. McGuire, M. J., Sykes, K. F., Samli, K. N., Timares, L., Barry, M. A., Stemke-Hale, K., Tagliaferri, F., Logan, M., Jansa, K., and Takashima, A. (2004) A library-selected, Langerhans cell-targeting peptide enhances an immune response DNA Cell Biol. 23, 742-752
18. McGuire, M. J., Samli, K. N., Chang, Y.-C., and Brown, K. C. (2006) Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas Exp. Hematol. 34, 443-452
19. Oyama, T., Rombel, I. T., Samli, K. N., Zhou, X., and Brown, K. C. (2006) Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries Biosens. Bioelectron. 21, 1867-1875
20. 6-specific ligand for in vitro and in vivo applications Mol. Cancer Ther. 8, 1239-1249
21. Loi, M., Marchio, S., Becherini, P., Di Paolo, D., Soster, M., Curnis, F., Brignole, C., Pagnan, G., Perri, P., Caffa, I., Longhi, R., Nico, B., Bussolino, F., Gambini, C., Ribatti, D., Cilli, M., Arap, W., Pasqualini, R., Allen, T. M., Corti, A., Ponzoni, M., and Pastorino, F. (2010) Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma J. Controlled Release 145, 66-73
22. Lowery, A., Onishko, H., Hallahan, D. E., and Han, Z. (2011) Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors J. Controlled Release 150, 117-124
23. Park, J. H., von Maltzahn, G., Xu, M. J., Fogal, V., Kotamraju, V. R., Ruoslahti, E., Bhatia, S. N., and Sailor, M. J. (2010) Cooperative nanomaterial system to sensitize, target, and treat tumors Proc. Natl. Acad. Sci. U. S. A. 107, 981-986
24. Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., Butler, J. S., Qin, L., Racie, T., Sprague, A., Fava, E., Zeigerer, A., Hope, M. J., Zerial, M., Sah, D. W., Fitzgerald, K., Tracy, M. A., Manoharan, M., Koteliansky, V., Fougerolles, A. d., and Maier, M. A. (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms Mol. Ther. 18, 1357-1364
25. Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., and Davies, N. M. (2003) Liposomal delivery of antigen to human dendritic cells Vaccine 21, 883-890
26. Espuelas, S., Haller, P., Schuber, F., and Frisch, B. (2003) Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers Bioorg. Med. Chem. Lett. 13, 2557-2560
27. Heurtault, B., Gentine, P., Thomann, J.-S., Baehr, C., Frisch, B., and Pons, F. (2008) Design of a liposomal candidate vaccine against pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity Pharm. Res. 26, 276-285
28. Martin, A. L., Li, B., and Gillies, E. R. (2009) Surface functionalization of nanomaterials with dendritic groups: toward enhanced binding to biological targets J. Am. Chem. Soc. 131, 734-741
29. 6 as a prognostic biomarker for nonsmall cell lung cancer Cancer Res. 67, 5889-5895
30. Ahmed, N., Riley, C., Rice, G. E., Quinn, M. A., and Baker, M. S. (2002) αvβ6 integrin-A marker for the malignant potential of epithelial ovarian cancer J. Histochem. Cytochem. 50, 1371
31. Arihiro, K., Kaneko, M., Fujii, S., Inai, K., and Yokosaki, Y. (2000) Significance of α9β1 and αvβ6 integrin expression in breast carcinoma Breast Cancer 7, 19-26
32. Bates, R. C., Bellovin, D. I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H., Sheppard, D., Oettgen, P., and Mercurio, A. M. (2005) Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma J. Clin. Invest. 115, 339-347
33. Hamidi, S., Salo, T., Kainulainen, T., Epstein, J., Lerner, K., and Larjava, H. (2000) Expression of αvβ6 integrin in oral leukoplakia Br. J. Cancer 82, 1433-1440
34. 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling J. Cell Sci. 108, 2241-2251
35. 6 is associated with lymph node metastasis Pathol. Res. Pract. 199, 57-64
36. Hazelbag, S., Kenter, G., Gorter, A., Dreef, E., Koopman, L., Violette, S., Weinreb, P., and Fleuren, G. (2007) Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival J. Pathol. 212, 316-324
37. Hecht, J. L., Dolinski, B. M., Gardner, H. A., Violette, S. M., and Weinreb, P. H. (2008) Overexpression of the αvβ6 integrin in endometrial cancer Appl. Immunohistochem. Mol. Morphol. 16, 543-547
38. Jones, J., Watt, F. M., and Speight, P. M. (1997) Changes in the expression of αv integrins in oral squamous cell carcinomas J. Oral Pathol. Med. 26, 63-68
39. Regezi, J. A., Ramos, D. M., Pytela, R., Dekker, N. P., and Jordan, R. C. K. (2002) Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas Oral Oncol. 38, 332-336
40. 6integrin in wound healing and cancer of the oral cavity J. Oral Pathol. Med. 35, 1-10
41. Prudkin, L., Liu, D. D., Ozburn, N. C., Sun, M., Behrens, C., Tang, X., Brown, K. C., Bekele, B. N., Moran, C., and Wistuba, I. I. (2009) Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung Modern Pathol. 22, 668-678
42. Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Carney, D., Minna, J. D., and Mulshine, J. L. (1996) NCI-navy medical oncology branch cell line data base J. Cell. Biochem. 63, 32-91
43. Shmeeda, H., Even-Chen, S., Honen, R., Cohen, R., Weintraub, C., and Barenholz, Y. (2003) Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies, In Methods Enzymology, Elsevier.
44. Abraham, S. A., Waterhouse, D. N., Mayer, L. D., Cullis, P. R., Madden, T. D., and Bally, M. B. (2005) The Liposomal Formulation of Doxorubicin, Vol. 391, Elsevier.
45. Dubey, P. K., Mishra, V., Jain, S., Mahor, S., and Vyas, S. (2004) Liposomes modified with cyclic RGD peptide for tumor targeting J. Drug Targeting 12, 257-264
46. Owens, D. E., 3rd and Peppas, N. A. (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307, 93-102
47. Moore, N. W. and Kuhl, T. L. (2006) The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces Biophys. J. 91, 1675-1687